XW Laboratories

XW Laboratories Inc. develops a portfolio of internally discovered product candidates for the potential treatment of neurological disorders.

XW Laboratories Inc. (XW Labs) is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates for the potential treatment of neurological disorders. XW Laboratories strives to become a leading China-based R&D company with its primary focus on the China market and via collaboration with other companies for foreign markets. XW Labs has established two platforms, Prodrug Platform and Functional Group Switch (FGS) Platform, both of which allow for quick paths to identify novel candidates by potentially reducing the development cost/time to achieve clinical Proof of Concept.